Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes.

Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes. Abstract Text:

    kunihiro suzukiKunihiro Suzuki,kohsuke uchidaKohsuke Uchida,nobuo nakanishiNobuo Nakanishi,yoshiyuki hattoriYoshiyuki Hattori,kunihiro suzukiKunihiro Suzuki,kohsuke uchidaKohsuke Uchida,nobuo nakanishiNobuo Nakanishi,yoshiyuki hattoriYoshiyuki Hattori,

    BackgroundEndothelial dysfunction plays a key role in atherogenesis. We investigated whether AMP-activated protein kinase (AMPK) activity is a downstream mediator of the beneficial effects of cilostazol on vascular endothelial cells and whether cilostazol might reverse endothelial dysfunction in diabetic rats.Methods and ResultsTreatment of human umbilical vein endothelial cells (HUVECs) with cilostazol resulted in time-dependent activation of AMPK, as monitored by phosphorylation of AMPK and its down-stream target, acetyl-CoA carboxylase (ACC). Activation of AMPK by cilostazol was through signaling pathway independent of cyclic AMP and caused phosphorylation of endothelial nitric oxide synthase (eNOS), leading to increased production of nitric oxide (NO), while inhibiting cytokine-induced nuclear factor-kappaB (NF-kappaB) activation, leading to suppression of VCAM-1 gene expression. Significantly reduced eNOS activity and NO production in response to cilostazol and attenuation of cilostazol-induced inhibition of NF-kappaB activation were observed in cells treated with AMPK siRNA. We also demonstrated that administration of cilostazol to diabetic rats significantly restored endothelium-dependent vasodilation. Furthermore, treatment of diabetic rats with cilostazol increased tetrahydrobiopterin (BH4) levels in the aorta. Thus, recovery of BH4 following administration of cilostazol might also contribute to restoration of endothelial function in diabetic rats.ConclusionsOur findings suggest that the beneficial effects of cilostazol on endothelial function may be due to AMPK activation. Restoration of endothelial dysfunction in diabetic rats by cilostazol is at least partly attributed to amelioration of biopterin metabolism in the aorta.American Journal of Hypertension (2008) doi:10.1038/ajh.2007.96American Journal of Hypertension (2008); 21 4. 451-457 doi:10.1038/ajh.2008.6.

    Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes. Publishing Authors By Initials

    k suzukiK Suzuki,k uchidaK Uchida,n nakanishiN Nakanishi,y hattoriY Hattori,k suzukiK Suzuki,k uchidaK Uchida,n nakanishiN Nakanishi,y hattoriY Hattori,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: American journal of hypertension : journal of the

    VOLUME: 21

    Page Numbers: 451-7

    Journal Abbreviation: Am. J. Hypertens.

    ISSN: 0895-7061

    DAY: 7

    MONTH: 02

    YEAR: 2008

    Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8803676

    Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes.

    AFFILIATION: 1Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Am J Hypertens

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News